Michael Rink

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

Évanguelos Xylinas, Michael Rink, K. Eugene et al. · European Urology · 2012 · 251 citations

Urology, Surgical Oncology, Distal Ureter Management +5

64-slice multidetector coronary CT angiography: in vitro evaluation of 68 different stents

David Maintz, Harald Seifarth, Rainer Raupach et al. · European Radiology · 2005 · 222 citations

Different Stents, Health Sciences, Medical Imaging +9

Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort

Atiqullah Aziz, Matthias May, Maximilian Burger et al. · European Urology · 2014 · 203 citations

Radical Cystectomy, Urology, Surgical Oncology +7

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt et al. · European Urology · 2019 · 189 citations · Full text